Peptide mimotopes of rabies virus glycoprotein with immunogenic activity.
about
Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold.Rabies Control and Treatment: From Prophylaxis to Strategies with Curative PotentialCharacterization of a human antibody fragment Fab and its calcium phosphate nanoparticles that inhibit rabies virus infection with vaccinePhages harboring specific peptides that recognize the N protein of the porcine reproductive and respiratory syndrome virus distinguish the virus from other virusesThe adaptation of a CTN-1 rabies virus strain to high-titered growth in chick embryo cells for vaccine development.Anti-idiotypic monobodies derived from a fibronectin scaffold.Architectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccinesSubtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applications.Evaluation of rabies biologics against Irkut virus isolated in China.Rabies virus vaccine as an immune adjuvant against cancers and glioblastoma: new studies may resurrect a neglected potential.Adaptation of a Chinese ferret badger strain of rabies virus to high-titered growth in BHK-21 cells for canine vaccine development.Immunocontraception: Filamentous Bacteriophage as a Platform for Vaccine Development.The self/nonself issue: A confrontation between proteomes.Selection strategy of phage-displayed immunogens based on an in vitro evaluation of the Th1 response of PBMCs and their potential use as a vaccine against Leishmania infantum infection.Antigen fingerprinting of polyclonal antibodies raised in immunized chickens with tick total proteins: a reservoir for the discovery of novel antigensImmunogenicity of NS4b Dengue 3 Virus Mimotope Presented to the Immune System as Multiple Antigen Peptide System
P2860
Q26795483-8DF00B4E-3203-44C7-8167-B04B5D9CCAF1Q28076429-F8999867-1F54-42EE-8615-1B17553D3EE7Q28740385-EC3964FC-9F34-454F-A978-43E2A20D6008Q33541811-1F25A6E2-858D-4CFA-8E41-A6B7DB885C2AQ33620685-6200DB4B-320B-4E4F-81C2-1DE6ECD3B41AQ33876210-A5D2035D-3A5B-485F-9909-1FF4909D6E8BQ34774808-8D7066FA-F170-4640-8CFE-7D6CBB0B4B2FQ35047624-CE18C44A-34F4-491B-8186-C8C440BC4233Q37470270-50B0DF16-5765-45AC-9090-CE1F929E7190Q39091380-BF73AE95-2905-4917-8A5F-CC64A81B69D3Q39299008-16F4D415-CE78-46CC-B1FC-84739346AA9CQ40044131-14E76BB5-A933-49F7-AA8B-8C2ED3C8CBB0Q42155059-75172201-9E32-4FCA-97E5-3825D9401A61Q48560747-69D5C267-AEE3-4BB9-A9CD-927E601BE0D9Q56892633-58AE04D8-51E6-4377-B1B1-415C3D03D92FQ59000638-6FC12ACE-ED41-4012-B34B-DF5EA24111A1
P2860
Peptide mimotopes of rabies virus glycoprotein with immunogenic activity.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Peptide mimotopes of rabies virus glycoprotein with immunogenic activity.
@ast
Peptide mimotopes of rabies virus glycoprotein with immunogenic activity.
@en
type
label
Peptide mimotopes of rabies virus glycoprotein with immunogenic activity.
@ast
Peptide mimotopes of rabies virus glycoprotein with immunogenic activity.
@en
prefLabel
Peptide mimotopes of rabies virus glycoprotein with immunogenic activity.
@ast
Peptide mimotopes of rabies virus glycoprotein with immunogenic activity.
@en
P1433
P1476
Peptide mimotopes of rabies virus glycoprotein with immunogenic activity.
@en
P2093
Mehdi Houimel
P304
P356
10.1016/J.VACCINE.2009.05.055
P407
P577
2009-06-09T00:00:00Z